Allowed codes
associatedWith
941 codes
- 2A60 – Acute myeloid leukaemias and related precursor neoplasms
- 2A61 – Acute leukaemias of ambiguous lineage
- 2A83.0 – Monoclonal gammopathy of undetermined significance
- 2A83.1 – Plasma cell myeloma
- 2A83.2 – Solitary plasmacytoma
- 2A83.3 – Extraosseous plasmacytoma
- 2A83.4 – Plasma cell leukaemia
- 2A83.5 – Monoclonal immunoglobulin deposition disease
- 2A85.4 – Lymphoplasmacytic lymphoma
- 2A8Z – Mature B-cell neoplasms, unspecified
- 2B30 – Hodgkin lymphoma
- 2B31 – Histiocytic or dendritic cell neoplasms
- 2B32 – Immunodeficiency-associated lymphoproliferative disorders
- 2B33 – Malignant haematopoietic neoplasms without further specification
- 2B3Z – Neoplasms of haematopoietic or lymphoid tissues, unspecified
- 2B57 – Kaposi sarcoma, primary site
- 2B70 – Malignant neoplasms of oesophagus
- 2B71 – Malignant neoplasms of oesophagogastric junction
- 2B72 – Malignant neoplasms of stomach
- 2C10 – Malignant neoplasm of pancreas
- 2C11 – Malignant neoplasms of other or ill-defined digestive organs
- 2C12 – Malignant neoplasms of liver or intrahepatic bile ducts
- 2C12.02 – Hepatocellular carcinoma of liver
- 2C13 – Malignant neoplasms of gallbladder
- 2C14 – Malignant neoplasms of proximal biliary tract, cystic duct
- 2C15 – Malignant neoplasms of biliary tract, distal bile duct
- 2C16 – Malignant neoplasms of ampulla of Vater
- 2C17 – Malignant neoplasms of other or unspecified parts of biliary tract
- 2C18 – Malignant neoplasms of perihilar bile duct
- 2C1Z – Malignant neoplasms of digestive organs, unspecified
- 2C20 – Malignant neoplasms of nasal cavity
- 2C21 – Malignant neoplasms of middle ear
- 2C22 – Malignant neoplasms of accessory sinuses
- 2C23 – Malignant neoplasms of larynx
- 2C24 – Malignant neoplasms of trachea
- 2C25 – Malignant neoplasms of bronchus or lung
- 2C26 – Malignant neoplasms of the pleura
- 2C27 – Malignant neoplasms of thymus
- 2C28 – Malignant neoplasms of heart or mediastinum
- 2C29 – Malignant neoplasms of other or ill-defined sites in the respiratory system or intrathoracic organs
- 2C60 – Carcinoma of breast, specialised type
- 2C61 – Invasive carcinoma of breast
- 2C62 – Inflammatory carcinoma of breast
- 2C63 – Malignant phyllodes tumour of breast
- 2C64 – Solid papillary carcinoma of breast with evidence of invasion
- 2C65 – Hereditary breast and ovarian cancer syndrome
- 2C6Y – Other specified malignant neoplasms of breast
- 2C6Z – Malignant neoplasms of breast, unspecified
- 2C77 – Malignant neoplasms of cervix uteri
- 2C90 – Malignant neoplasms of kidney, except renal pelvis
- 2C91 – Malignant neoplasms of renal pelvis
- 2C92 – Malignant neoplasms of ureter
- 2C93 – Malignant neoplasms of urethra or paraurethral gland
- 2C94 – Malignant neoplasms of bladder
- 2C95 – Malignant neoplasm involving overlapping sites of urinary organs
- 2C9Y – Other specified malignant neoplasms of urinary tract
- 2C9Z – Malignant neoplasms of urinary tract, unspecified
- 2E66 – Carcinoma in situ of cervix uteri
- 2F31 – Benign non-mesenchymal neoplasms of uterus
- 3A50 – Thalassaemias
- 3A51 – Sickle cell disorders or other haemoglobinopathies
- 3A70 – Aplastic anaemia
- 3A71 – Anaemia due to chronic disease
- 3A72 – Sideroblastic anaemia
- 3A73 – Congenital dyserythropoietic anaemia
- 3A90 – Anaemia due to acute disease
- 3A91 – Congenital methaemoglobinaemia
- 3A92 – Hereditary methaemoglobinaemia
- 3A93 – Acquired methaemoglobinaemia
- 3A94 – Acute posthaemorrhagic anaemia
- 3A9Y – Other specified anaemias or erythrocyte disorders
- 3A9Z – Anaemias or other erythrocyte disorders, unspecified
- 3B4Z – Coagulation defects, unspecified
- 3B64 – Thrombocytopenia
- 3C0Y – Other specified diseases of the blood or blood-forming organs
- 3C0Z – Diseases of the blood or blood-forming organs, unspecified
- 4A20 – Acquired immunodeficiencies
- 4A40 – Lupus erythematosus
- 4A40.0 – Systemic lupus erythematosus
- 4A43.2 – Sjögren syndrome
- 4A44 – Vasculitis
- 4A44.2 – Giant cell arteritis
- 4A44.Y – Other specified vasculitis
- 4A45 – Antiphospholipid syndrome
- 4A60 – Monogenic autoinflammatory syndromes
- 4A62 – Behçet disease
- 4B00 – Disorders of neutrophil number
- 4B20 – Sarcoidosis
- 4B40 – Diseases of thymus
- 4B4Y – Other specified diseases of the immune system
- 4B4Z – Diseases of the immune system, unspecified
- 5A02 – Thyrotoxicosis
- 5A03 – Thyroiditis
- 5A10 – Type 1 diabetes mellitus
- 5A11 – Type 2 diabetes mellitus
- 5A12 – Malnutrition-related diabetes mellitus
- 5A13 – Diabetes mellitus, other specified type
- 5A14 – Diabetes mellitus, type unspecified
- 5A51 – Hyperparathyroidism
- 5B50 – Underweight in infants, children or adolescents